Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer

被引:111
|
作者
Zou, Peng [1 ,2 ]
Xia, Yiqun [3 ]
Ji, Jiansong [4 ]
Chen, Weiqian [1 ,4 ]
Zhang, Jinsan [1 ]
Chen, Xi [1 ]
Rajamanickam, Vinothkumar [1 ]
Chen, Gaozhi [1 ]
Wang, Zhe [1 ]
Chen, Lingfeng [1 ]
Wang, Yifeng [1 ]
Yang, Shulin [2 ]
Liang, Guang [1 ]
机构
[1] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China
[2] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing 210094, Jiangsu, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Digest Dis, Wenzhou 325035, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Lishui 323000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Thioredoxin reductase 1; Reactive oxygen species; Piperlongumine; ER stress; Mitochondrial dysfunction; THIOREDOXIN REDUCTASE 1; REACTIVE OXYGEN; CELL-DEATH; APOPTOSIS; STRESS; ACTIVATION; RESISTANCE; TRASTUZUMAB; GLUTATHIONE; MECHANISMS;
D O I
10.1016/j.canlet.2016.02.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Piperlongumine (PL), a natural alkaloid isolated from the fruit of long pepper, is known to selectively kill tumor cells while sparing their normal counterparts. However, the cellular target and potent anticancer efficacy of PL in numerous types of human cancer cells have not been fully defined. We report here that PL may interact with the thioredoxin reductase 1 (TrxR1), an important selenocysteine (Sec) containing antioxidant enzyme, to induce reactive oxygen species (ROS)-mediated apoptosis in human gastric cancer cells. By inhibiting TrxR1 activity and increasing intracellular ROS levels, PL induces a lethal endoplasmic reticulum stress and mitochondrial dysfunction in human gastric cancer cells. Importantly, knockdown of TrxR1 sensitizes cells to PL treatment, and PL displays synergistic lethality with GSH inhibitors (BSO and Erastin) against gastric cancer cells. In vivo, PL treatment markedly reduces the TrxR1 activity and tumor cell burden. Remarkably, TrxR1 was significantly overexpressed in gastric cancer cell lines and human gastric cancer tissues. Targeting TrxR1 with PL thus discloses a previously unrecognized mechanism underlying the biological activity of PL and provides an in-depth insight into the action of PL in the treatment of gastric cancer. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:114 / 126
页数:13
相关论文
共 50 条
  • [11] Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells
    Zheng, Peisen
    Xia, Yiqun
    Shen, Xin
    Lu, Hui
    Chen, Yinghua
    Xu, Chenxin
    Qiu, Chenyu
    Zhang, Yafei
    Zou, Peng
    Cui, Ri
    Huang, Xiaoying
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (01): : 249 - 264
  • [12] Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer
    U Bharadwaj
    T K Eckols
    M Kolosov
    M M Kasembeli
    A Adam
    D Torres
    X Zhang
    L E Dobrolecki
    W Wei
    M T Lewis
    B Dave
    J C Chang
    M D Landis
    C J Creighton
    M A Mancini
    D J Tweardy
    Oncogene, 2015, 34 : 1341 - 1353
  • [13] Thimerosal, a competitive thioredoxin reductase 1 (TrxR1) inhibitor discovered via high-throughput screening
    Ni, Yicheng
    Luo, Zhongyuan
    Lv, Yixin
    Ma, Shuyuan
    Luo, Cheng
    Du, Daohai
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 650 : 117 - 122
  • [14] Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation
    Chen, Weiqian
    Zou, Peng
    Zhao, Zhongwei
    Weng, Qiaoyou
    Chen, Xi
    Ying, Shilong
    Ye, Qingqing
    Wang, Zhe
    Ji, Jiansong
    Liang, Guang
    ONCOTARGET, 2016, 7 (13) : 16593 - 16609
  • [15] Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer
    Bharadwaj, U.
    Eckols, T. K.
    Kolosov, M.
    Kasembeli, M. M.
    Adam, A.
    Torres, D.
    Zhang, X.
    Dobrolecki, L. E.
    Wei, W.
    Lewis, M. T.
    Dave, B.
    Chang, J. C.
    Landis, M. D.
    Creighton, C. J.
    Mancini, M. A.
    Tweardy, D. J.
    ONCOGENE, 2015, 34 (11) : 1341 - 1353
  • [16] Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells
    Shen, Xin
    Xia, Yiqun
    Lu, Hui
    Zheng, Peisen
    Wang, Junqi
    Chen, Yinghua
    Xu, Chenxin
    Qiu, Chenyu
    Zhang, Yafei
    Xiao, Zhongxiang
    Zou, Peng
    Cui, Ri
    Ni, Daoyong
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [17] Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway
    He, Wei
    Cao, Peihai
    Xia, Yiqun
    Hong, Lin
    Zhang, Tingting
    Shen, Xin
    Zheng, Peisen
    Shen, Huanpei
    Zhao, Yunjie
    Zou, Peng
    FREE RADICAL RESEARCH, 2019, 53 (01) : 104 - 114
  • [18] Direct growth suppressive activity of interferon-α and -γ on human gastric cancer cells
    Shyu, RY
    Su, HL
    Yu, JC
    Jiang, SY
    JOURNAL OF SURGICAL ONCOLOGY, 2000, 75 (02) : 122 - 130
  • [19] Licochalcone a Induces ROS-Mediated Apoptosis through TrxR1 Inactivation in Colorectal Cancer Cells
    Wu, Peng
    Yu, Ting
    Wu, Jun
    Chen, Junfeng
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [20] RETRACTION: Retraction Note: Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer (Retraction of Vol 40, art no 260, 2021)
    Zhang, Haiyong
    Wu, Jing
    Yuan, Jinqiu
    Li, Huafu
    Zhang, Yawei
    Wu, Wang
    Chen, Wei
    Wang, Chunming
    Meng, Sijun
    Chen, Songyao
    Huo, Mingyu
    He, Yulong
    Zhang, Changhua
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)